Global /India /Healthcare /Medical Care Facilities /NEPHROCARE

Nephro Care India Ltd.

NEPHROCARE

• NSE: NEPHROCARE • Delayed

88.60INR 2.3%

0.9289 USD

As of 7 June 2026, Nephro Care India Ltd. has a market cap of $15.26M USD, ranking #38888 globally and #2865 in India. It ranks #3471 in the Healthcare sector, and #417 in the Medical Care Facilities industry.

Global Rank

38888

Country Rank

2865

Sector Rank

3471

Industry Rank

417

Key Stats

Market Cap

$15.26MUSD

1.46B INR

Enterprise Value

$13.84MUSD

1.32B INR

Revenue (TTM)

$7.95MUSD

761.59M INR

EBITDA (TTM)

$787.44KUSD

75.11M INR

Net Income (TTM)

$322.86KUSD

30.91M INR

EBITDA Margin

9.9%

Profit Margin

4.1%

PE Ratio

54.9

PS Ratio

1.9

PB Ratio

2.6

EV/EBITDA

17.6

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Pratim Sengupta open_in_new

Employees

334

Founded

2014

Website

nephrocareindia.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.3%	-0.7%	66%	-15%	-38%	-22%	-40%	-57%	-57%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	NEPHROCARE Nephro Care India Ltd ISIN: INE0SUN01013 TV: TradingView: NSE: NEPHROCARE SA: Stock Analysis: NSE: NEPHROCARE YF: Yahoo Finance: NEPHROCARE.NS GF: Google Finance: NSE: NEPHROCARE BA: Barron's: NEPHROCARE MS: Morningstar: XNSE: NEPHROCARE	88.60 INR	TV: TradingView: NSE: NEPHROCARE SA: Stock Analysis: NSE: NEPHROCARE YF: Yahoo Finance: NEPHROCARE.NS GF: Google Finance: NSE: NEPHROCARE BA: Barron's: NEPHROCARE MS: Morningstar: XNSE: NEPHROCARE

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Nephro Care India Ltd.

Nephro Care India Limited, provides treatment for kidney-related diseases in India. The company offers care for renal failure patients that include consultation, treatment, and yoga; nutritional support, including nutritional support for weight loss/weight gain, body composition analysis, anthropometry, and lifestyle education and support services for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, lupus nephropathy, and ADPKD; and lifestyle and rehabilitation programs. Its clinics provides renal transplant, urology, vascular surgery, carepath diagnostics, digital radiology, cardiology, OT facilities, women welfare services. In addition, the company offers pulmonary function test, EMG/NCV-testing, uroflowmetry, EEG, polysomnography, and retinal screening services. The company was incorporated in 2014 and is based in Kolkata, India.

Similar Companies

Industry: Medical Care Facilities (India)

Name	Market Cap (USD) diff.	PE	Country
Apollo Hospitals Enterprise Ltd. NSE: APOLLOHOSP	$11.47B 1.1T INR 75K%	60.9	India
Max Healthcare Institute Ltd. NSE: MAXHEALTH	$10.22B 978.68B INR 67K%	69.0	India
Fortis Healthcare Ltd. NSE: FORTIS	$7.37B 706.04B INR 48K%	73.6	India
Narayana Hrudayalaya Ltd. NSE: NH	$3.76B 359.57B INR 25K%	46.2	India
Global Health Ltd. NSE: MEDANTA	$3.14B 300.37B INR 20K%	58.5	India
Krishna Institute of Medical Sciences Ltd. NSE: KIMS	$2.78B 266.19B INR 18K%	88.6	India

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 2M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 634K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 175K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 168K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 147K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 138K%	24.6	United States

chevron_leftBack